SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-038151
Filing Date
2022-03-25
Accepted
2022-03-25 16:58:29
Documents
9
Period of Report
2022-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm223557-1_def14a.htm DEF 14A 2025903
2 GRAPHIC lg_anipharma-bw.jpg GRAPHIC 12806
3 GRAPHIC sg_nikhillalwani-bw.jpg GRAPHIC 20766
4 GRAPHIC sg_stephenpcarey-bw.jpg GRAPHIC 9336
5 GRAPHIC tm223557d1-icon_tickmark.jpg GRAPHIC 1121
6 GRAPHIC tm223557d1-icon_worngmark.jpg GRAPHIC 2092
7 GRAPHIC tm223557d1-pc_average4c.jpg GRAPHIC 103696
8 GRAPHIC tm223557d1-px_01pagebw.jpg GRAPHIC 524838
9 GRAPHIC tm223557d1-px_02pagebw.jpg GRAPHIC 462824
  Complete submission text file 0001104659-22-038151.txt   3594626
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31812 | Film No.: 22772149
SIC: 2834 Pharmaceutical Preparations